Affymetrix to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
February 01 2006 - 4:00PM
Business Wire
Affymetrix, Inc. (Nasdaq:AFFX) today announced it will webcast its
presentation at the Merrill Lynch Global Pharmaceutical,
Biotechnology and Medical Device Conference in New York City. Greg
Schiffman, Executive Vice President and Chief Financial Officer,
will provide a company overview at 4:00 p.m. ET on Wednesday,
February 8th. A webcast of the presentation will be available live
and by replay. To access both the live and archived webcast, please
go to www.affymetrix.com and click on the "Investors" link. The
archived replay will be available 24 hours after the live
presentation and will be accessible for 30 days. About Affymetrix:
Affymetrix scientists invented the world's first high-density
microarray in 1989 and began selling the first commercial
microarray in 1994. Since then, Affymetrix GeneChip(R) technology
has become the industry standard in molecular biology research.
Affymetrix technology is used by the world's top pharmaceutical,
diagnostic and biotechnology companies as well as leading academic,
government and not-for-profit research institutes. More than 1,300
systems have been installed around the world and nearly 3,000
peer-reviewed papers have been published using the technology.
Affymetrix' patented photolithographic manufacturing process
provides the most information capacity available today on an array,
enabling researchers to use a whole-genome approach to analyzing
the relationship between genetics and health. Affymetrix is
headquartered in Santa Clara, Calif., with manufacturing facilities
in Sacramento, Calif., and Bedford, Mass. The company maintains
important sales and marketing operations in Europe and Asia and has
about 1,000 employees worldwide. For more information about
Affymetrix, please visit the company's website at
www.affymetrix.com. NOTE: Affymetrix, the Affymetrix logo, and
GeneChip are registered trademarks owned or used by Affymetrix,
Inc.
Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Jul 2023 to Jul 2024